Dexcom (DXCM) Payables (2010 - 2026)

Dexcom (DXCM) has 17 years of Payables data on file, last reported at $2.1 billion in Q1 2026.

• Quarterly Payables fell 28.38% year-over-year to $2.1 billion in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $2.1 billion (down 28.38% YoY) and the FY2025 annual result came in at $1.9 billion, down 30.31% from the prior year.
• Payables advanced to $2.1 billion in Q1 2026 per DXCM's latest filing, from $1.9 billion in the prior quarter.
• Across five years, Payables topped out at $3.1 billion in Q2 2025 and bottomed at $603.1 million in Q1 2022.
• The 5-year median for Payables is $1.7 billion (2022), against an average of $1.8 billion.
• The widest annual swing landed in 2022, when Payables surged 192.22%; it then slumped 30.31% in 2025.
• Tracing DXCM's Payables over 5 years: stood at $1.7 billion in 2022, then decreased by 19.64% to $1.3 billion in 2023, then surged by 107.32% to $2.8 billion in 2024, then tumbled by 30.31% to $1.9 billion in 2025, then gained by 6.68% to $2.1 billion in 2026.
• Per Business Quant, the three latest DXCM Payables figures stand at $2.1 billion (Q1 2026), $1.9 billion (Q4 2025), and $3.1 billion (Q3 2025).

Peer Comparison